[Form 4] PROCTER & GAMBLE Co Insider Trading Activity

Rhea-AI Filing Summary

JIMENEZ JOSEPH reported acquisition or exercise transactions in this Form 4 filing.

PROCTER & GAMBLE Co director Joseph Jimenez received a grant of 273 shares of Common Stock in the form of restricted stock units. The award was made at no cash price as part of The Procter & Gamble 2025 Stock and Incentive Compensation Plan and includes dividend equivalents credited as additional units. After this compensation-related grant, his directly held position reported in this filing increased to 36,512.1482 shares of Common Stock, showing this is a relatively small, routine addition to an existing stake rather than a market purchase or sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JIMENEZ JOSEPH

(Last) (First) (Middle)

ONE PROCTER & GAMBLE PLAZA

(Street)

CINCINNATI OH 45202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PROCTER & GAMBLE Co [ PG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		A		273	A	$0(1)	36,512.1482(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan.

2. Total includes grant of dividend equivalents in the form of Restricted Stock Units.

	/s/ Wednesday Shipp, attorney-in-fact for Joseph Jimenez	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Procter & Gamble (PG) director Joseph Jimenez report in this Form 4?

Joseph Jimenez reported receiving 273 shares of Procter & Gamble Common Stock as a restricted stock unit award. The grant was part of the company’s 2025 Stock and Incentive Compensation Plan and reflects equity-based compensation rather than an open-market trade.

How many Procter & Gamble (PG) shares does Joseph Jimenez hold after this award?

Following the reported restricted stock unit grant, Joseph Jimenez holds 36,512.1482 shares of Procter & Gamble Common Stock directly. This figure includes the newly granted units and previously held shares, giving investors a snapshot of his total reported equity stake.

Was cash paid for the Procter & Gamble (PG) shares granted to Joseph Jimenez?

No cash was paid for these shares; the reported transaction price per share is zero. The 273 shares were awarded as restricted stock units under Procter & Gamble’s 2025 Stock and Incentive Compensation Plan, making this a compensation grant, not a market purchase.

What plan governs the restricted stock units granted to Procter & Gamble (PG) director Joseph Jimenez?

The restricted stock units were awarded under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Footnotes explain that the total also includes dividend equivalents paid in additional restricted stock units, tying the grant directly to the company’s long-term incentive program.

Do the Procter & Gamble (PG) restricted stock units for Joseph Jimenez include dividend equivalents?

Yes, the reported total includes dividend equivalents granted as additional restricted stock units. This means dividends that would have been paid on underlying shares are instead credited as more units, modestly increasing the director’s equity-based compensation over time.